What Are The Chances Of Merck & Co Inc (NYSE: MRK) Becoming A Clear Buy?

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

As a NYSE listed company, MRK falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. The current market capitalization of Merck & Co Inc is $279.29B. A total of 10.26 million shares were traded on the day, compared to an average of 9.22M shares.

In the most recent transaction, Merck & Co., Inc. bought 21,397,205 shares of MRK for 23.00 per share on Mar 11 ’24. After the transaction, the 10% Owner now owns 1,000 company shares. In a previous transaction on Feb 14 ’24, Litchfield Caroline sold 38,291 shares at 125.50 per share. MRK shares that EVP & CFO owns now total 50,908.

Among the insiders who sold shares, Davis Robert M disposed of 150,000 shares on Feb 13 ’24 at a per-share price of $125.85. This resulted in the Chairman, CEO & President holding 348,327 shares of MRK after the transaction. In another insider transaction, Davis Robert M sold 85,021 shares at $125.40 per share on Feb 14 ’24. Company shares held by the Chairman, CEO & President now total 348,327.

Dividend

Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Merck & Co Inc pays an annual dividend of $3.08, resulting in a dividend yield of 2.80%, and it has a price to earnings (P/E) ratio of 20.42. MRK’s most recent ex-dividend date was 9/16/2024 when it declared a $0.77 quarterly dividend that was paid in cash on 10/7/2024. Previously, the company paid the dividend on 7/8/2024 with an ex-dividend date of 6/17/2024. The MRK stock dividend was $0.77 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, MRK has a high of $134.63 and a low of $99.14.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. MRK’s latest balance sheet shows that the firm has $8.10B in Cash & Short Term Investments as of fiscal 2021. There were $33.10B in debt and $23.87B in liabilities at the time. Its Book Value Per Share was $17.19, while its Total Shareholder’s Equity was $38.26B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRK is Buy with a score of 4.84.

Most Popular

Related Posts